Latest News

Reports
0SfN 2018: Day 4 Update

Not able to attend SfN 2018 this year? You can catch up with all the action from today with our daily video, best of social media and the biggest headlines.

Journal Articles

Autoimmune

Could hyaluronic acid contribute to chronic white matter injury?

Can living in a sunnier climate in your youth reduce the risk of MS?

Could transcranial direct current stimulation offer relief from fatigue in multiple sclerosis sufferers?

Cerebrovascular disease

ANA 2018: key highlights and news stories

World Stroke Congress 2018: key news stories and hot topics

Could a simple test predict long-term stroke recovery?

CNS/PNS/SNS

SfN18: Advances in brain–computer interfaces may improve therapies and prosthetics

Breakthrough spinal implant helps paralyzed men walk again

Spina bifida fetal surgery offered for the first time in the UK

Cognitive/neurodegenerative disorders

SfN18: What are the neural risks and benefits of marijuana use? New studies shed light

SfN18: New strategies for identifying causes of vascular dementia

SfN18: Exosomes could have wide-ranging and long-term effects in the brain and body

Demyelinating disease

Multiple sclerosis: potential risk factors, cognitive impairment and the microbiome

Identification of a new subtype of multiple sclerosis: an interview with Bruce Trapp

ECTRIMS 2018: Day 3 Update

Development and pediatrics

SfN18: What are the neural risks and benefits of marijuana use? New studies shed light

SfN18: The adolescent brain, mental health and substance abuse

SfN18: The potential of gene therapy in neurological disorders

Epilepsy and seizure

Cannabidiol for epilepsy expected to be available within 6 weeks: industry news round-up

First FDA-approved cannabinoid-derived drug for seizures

Epilepsy and cannabinoids: current consensus, controversies and future outlook

Genetics

SfN18: The potential of gene therapy in neurological disorders

Treasure trove of 102 genes associated with autism identified

Monogenic neurodevelopmental disorders may not be as simple as they seem

Headache

Alzheimer’s drug development halted following toxic reaction: industry news round-up

Aimovig® receives EMA license for the prevention of migraine

Aimovig® receives positive CHMP opinion for the prevention of migraine

Immune disorders and inflammation

Inflammatory disease and anxiety: could endocannabinoids be a mechanism of comorbidity?

FENS 2018: Immune system offers new way of treating Alzheimer’s disease

FENS 2018: Could anxiety and inflammation be treated with cannabis?

Infection

ANA 2018: key highlights and news stories

Further evidence links herpes virus to Alzheimer’s disease

Could Alzheimer’s disease be kick-started by periodontal bacteria?

Injury/trauma

Breakthrough spinal implant helps paralyzed men walk again

Is brain cooling after a traumatic brain injury beneficial for patients?

Spinal cord stimulation enables paralyzed man to walk

Movement disorders

BrainStorm scraps initial access to NurOwn® for amyotrophic lateral sclerosis

Parkinson’s drugs may cause impulse control disorders

Is there a link between diabetes and Parkinson’s disease?

Neuro-ophthalmology

Vision in Alzheimer's disease: a focus on the anterior afferent pathway

Glaucoma research gives a glimpse of a novel neuroprotection mechanism

Management of glaucoma as a neurodegenerative disease

Neurometabolic

Epigenetics, opioids and immune regulation: interviews from SfN17

Jeffrey Iliff: glymphatics, Alzheimer’s and future directions

SfN17: Neurodegeneration and the microbiome – new research highlights

Neuromuscular

New genetic suspects identified for ALS and FTD

Novel discovery in motor neuron disease may pave the way for future treatments

EAN 2017: Guillain-Barré syndrome risk associated with month of birth

Neuropsychiatry

SfN18: Can animal models offer an insight into human opioid addiction, withdrawal and relapse behaviors?

SfN18: The adolescent brain, mental health and substance abuse

Combination therapy targeting the opioid system may help with major depression

Oncology/tumor

Could combination therapy be the future of neuroblastoma treatment?

Brain tumor liquid biopsies are on the horizon

Zika vaccine yields promising results for treating glioblastoma

Pain

Spinal cord stimulation enables paralyzed man to walk

Chronic pain relief: medical marijuana study identifies possible change in brain connections

NCTalks with Irene Tracey: lessons from pain, analgesia and anesthesia

Sleep

SfN18: Disrupted sleep may exacerbate anxiety and brain disorders

#NCIntroduces... Sleep science

Better sleep works like a dream at reducing fear learning